Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in AUD
The 4 analysts offering 12 month price targets for PYC Therapeutics Ltd have a median target of 0.32, with a high estimate of 0.44 and a low estimate of 0.24. The median estimate represents a 64.10% increase from the last price of 0.195.
High | 125.6% | 0.44 |
Med | 64.1% | 0.32 |
Low | 23.1% | 0.24 |
Earnings history & estimates in AUD
Average growth rate | -31.55% |
More ▼
Revenue history & estimates in AUD
Average growth rate | +483.81% |
More ▼